Mona Amini-Adle (M Amini Adle, M Amini-Adle)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 7

Top Topics

Ejection Fraction

Prognostic Factors

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Top Venues

Clinical and experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

L Bottlaender, Mona Amini-Adle, D Maucort-Boulch, P Robinson, Luc Thomas, S Dalle
Cutaneous adverse events: a predictor of tumour response under anti-PD-1 therapy for metastatic melanoma, a cohort analysis of 189 patients. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
V Carlioz, M Perier-Muzet, Sébastien Debarbieux, Mona Amini-Adle, Stéphane Dalle, G Duru, Luc Thomas
Intraoperative dermoscopy features of subungual squamous cell carcinoma: a study of 53 cases. Clinical and experimental dermatology 46 (1) (2020)
Mona Amini-Adle, M Chastagner, S Mansard, S Dalle
Image Gallery: Unilateral eyebrow depigmentation. The British journal of dermatology 180 (4) (2020)
M Danset, S Milley, O Harou, D Vasseur, Mona Amini-Adle, L Thomas, S Dalle, B Balme, Jonathan Lopez
Concomitant GNA11 and SF3B1 mutations in two cases of melanoma associated with blue naevus. Clinical and experimental dermatology 45 (1) (2019)
L Gouillon, M Perier-Muzet, Mona Amini-Adle, N Poulalhon, S Debarbieux, A Boespflug, B Balme, L Depaepe, O Harou, J Lopez, P-P Bringuier, C Ferraro-Peyret, D Maucort-Boulch, P Robinson, Luc Thomas, S Dalle
Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue-white veil. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (2) (2019)
Mona Amini-Adle, Muriel Piperno, Jérémie Tordo, Luc Thomas, Stéphane Dalle, Valérie Dubois, Aurélien Marabelle
Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment. Arthritis & rheumatology (Hoboken, N.J.) 70 (8) (2018)
Mona Amini-Adle, N Khanafer, M Le-Bouar, G Duru, S Dalle, L Thomas
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma. BMC cancer 18 (1) (2018)